Compare Ascendis Pharma A/S (ASND) vs GoPro Inc (GPRO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ascendis Pharma A/S vs GoPro Inc — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while GoPro Inc trades at $0.63 (market cap $114.41M). The key difference: Ascendis Pharma A/S is far larger — about 145.7× GoPro Inc's market cap, and Ascendis Pharma A/S is trading nearer its 52-week high, GoPro Inc nearer its low. Which is the better fit depends on your goals.
| ASND | GPRO | |
|---|---|---|
Market Cap | $16.67B | $114.41M |
Sector | Health | Technology |
52-Week High | $277.18 | $2.88 |
52-Week Low | $189.74 | $0.62 |
Enterprise Value | $17.04B | $173.19M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →About GoPro Inc
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
Read more on GPRO →
